Related Experiment Video

Updated: Apr 27, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K

The impact of atrial fibrillation and its treatment on dementia

Arun Kanmanthareddy1, Ajay Vallakati, Arun Sridhar

  • 1Cardiovascular Research Institute, Bloch Heart Rhythm Center, University of Kansas Hospital, Kansas City, KS, USA.

Current Cardiology Reports
|June 30, 2014
PubMed

Insights

Atrial fibrillation (AF) increases dementia risk through stroke and altered blood flow. Maintaining sinus rhythm via catheter ablation may reduce this risk.

Area of Science:

  • Cardiology
  • Neurology
  • Gerontology

Background:

  • Atrial fibrillation (AF) is a prevalent tachyarrhythmia.
  • Dementia is a neurological condition characterized by cognitive decline.
  • Shared risk factors link AF and dementia, with AF increasingly recognized as a risk factor for dementia.

Purpose of the Study:

  • To explore the link between atrial fibrillation and dementia.
  • To identify pathophysiological mechanisms connecting AF to dementia.
  • To evaluate interventions for mitigating dementia risk in AF patients.

Main Methods:

  • Review of existing literature on AF, dementia, and associated risk factors.
  • Analysis of pathophysiological pathways including stroke, cerebral blood flow, and microbleeds.
  • Examination of the role of maintaining sinus rhythm and catheter ablation.

Main Results:

  • AF significantly increases stroke risk, a known contributor to dementia.
  • Altered cerebral blood flow and microbleeds in AF patients may also elevate dementia risk.
  • Maintaining sinus rhythm, potentially through catheter ablation, shows promise in reducing dementia risk.

Conclusions:

  • AF is a modifiable risk factor for dementia.
  • Catheter ablation offers a strategy to maintain sinus rhythm and potentially decrease dementia incidence.
  • Aggressive risk factor management alongside rhythm control and anticoagulation is crucial for dementia prevention in AF patients.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.8K

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
685
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
595
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K